Yan Ding
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 10
- Biochemistry top 2%
- Molecular Biology top 5%
- RNA modifications and cancer 14
- Epigenetics and DNA Methylation 9
- Circular RNAs in diseases 9
- Pluripotent Stem Cells Research 8
- Ubiquitin and proteasome pathways 6
- Water Science and Technology top 5%
-
- Autophagy in Disease and Therapy 8
- Journals
- Journal of Hazardous Materials (4 papers)Frontiers in Oncology (3 papers)Cell Death Discovery (3 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Yan Ding
147 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 1.0k
- Biochemistry 246
- Molecular Biology 1.7k
- Water Science and Technology 218
- Endocrinology, Diabetes and Metabolism 247
Countries citing papers authored by Yan Ding
This map shows the geographic impact of Yan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ding more than expected).
Fields of papers citing papers by Yan Ding
This network shows the impact of papers produced by Yan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ding. The network helps show where Yan Ding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 50 | |
| 14 | 2022 | 19 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 44 | |
| 17 | Evaluation of the antioxidant effect of scoparone and scopoletin from Artemisia capillaries | 2016 | 1 |
| 18 | 2010 | 347 | |
| 19 | Financial Challenges in Compulsory Education and Intergovernmental Education Grants | 2003 | 3 |
| 20 | Studies on the chemical constituents of Cucurbita pepo cv dayangua | 2002 | 2 |
About Yan Ding
Yan Ding is a scholar working on Cancer Research, Microbiology and Molecular Biology, having authored 160 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (14 papers), MicroRNA in disease regulation (10 papers), Epigenetics and DNA Methylation (9 papers), Circular RNAs in diseases (9 papers), Autophagy in Disease and Therapy (8 papers), Pluripotent Stem Cells Research (8 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Cancer Research (1.0k citations), Biochemistry (246 citations) and Molecular Biology (1.7k citations). Yan Ding has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Ming Tan, Øystein Fodstad, Yuhua Zhao, Jinbao Liu, Xin Chen, Daolin Tang, Ming Zhou, Kangping Cui, Yihan Chen and Qian‐Li Xue. Their work appears in journals such as Journal of Hazardous Materials, Frontiers in Oncology, Cell Death Discovery, Oncology Reports and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.